Epidermal Growth Factor Receptor–Specific Nanoprobe Biodistribution in Mouse Models
- 1 January 2016
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 105 (1) , 25-30
Abstract
No abstract availableKeywords
Funding Information
- Department of Foreign Affairs, Trade and Development Canada
- Nova Scotia Health Research Foundation
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (400617/2012-9, 301022/2012-7)
This publication has 18 references indexed in Scilit:
- Development of a sensitive, stable and EGFR‐specific molecular imaging agent for surface enhanced Raman spectroscopyJournal of Raman Spectroscopy, 2015
- Nanobiophotonics for molecular imaging of cancer: Au- and Ag-based Epidermal Growth Factor receptor (EGFR) specific nanoprobes2012
- Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administrationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Toxicologic effects of gold nanoparticles in vivo by different administration routesInternational Journal of Nanomedicine, 2010
- Imaging EGFR distribution using surface-enhanced Raman spectroscopy2009
- Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle sizeColloids and Surfaces B: Biointerfaces, 2008
- Epidermal growth factor receptors in non-small cell lung cancerBritish Journal of Cancer, 1987
- Over‐expression of the EGF receptor is a hallmark of squamous cell carcinomasThe Journal of Pathology, 1986
- Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer.Journal of Clinical Pathology, 1985
- EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURSThe Lancet, 1985